These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Mazzone E; Martinelli D; Berardinelli A; Messina S; D'Amico A; Vasco G; Main M; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Carlesi A; Bonetti AM; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Pasquini E; Bruno C; Vita G; de Waure C; Bertini E; Mercuri E Neuromuscul Disord; 2010 Nov; 20(11):712-6. PubMed ID: 20634072 [TBL] [Abstract][Full Text] [Related]
44. Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy. Liu CY; Yao J; Kovacs WC; Shrader JA; Joe G; Ouwerkerk R; Mankodi AK; Gahl WA; Summers RM; Carrillo N Neurology; 2021 Feb; 96(5):e798-e808. PubMed ID: 33219145 [TBL] [Abstract][Full Text] [Related]
45. A Comparison between 6-point Dixon MRI and MR Spectroscopy to Quantify Muscle Fat in the Thigh of Subjects with Sarcopenia. Grimm A; Meyer H; Nickel MD; Nittka M; Raithel E; Chaudry O; Friedberger A; Uder M; Kemmler W; Engelke K; Quick HH J Frailty Aging; 2019; 8(1):21-26. PubMed ID: 30734827 [TBL] [Abstract][Full Text] [Related]
46. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series. Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189 [TBL] [Abstract][Full Text] [Related]
47. Muscle MRI: A biomarker of disease severity in Duchenne muscular dystrophy? A systematic review. Ropars J; Gravot F; Ben Salem D; Rousseau F; Brochard S; Pons C Neurology; 2020 Jan; 94(3):117-133. PubMed ID: 31892637 [TBL] [Abstract][Full Text] [Related]
48. Analysis of motor and respiratory function in Duchenne muscular dystrophy patients. Luiz LC; Marson FAL; Bresciani Almeida CC; Toro AADC; Nucci A; Ribeiro JD Respir Physiol Neurobiol; 2019 Apr; 262():1-11. PubMed ID: 30660861 [TBL] [Abstract][Full Text] [Related]
49. Elevated phosphodiester and T Hooijmans MT; Niks EH; Burakiewicz J; Verschuuren JJ; Webb AG; Kan HE NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27859827 [TBL] [Abstract][Full Text] [Related]
50. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1. Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385 [TBL] [Abstract][Full Text] [Related]
51. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. Fischmann A; Hafner P; Gloor M; Schmid M; Klein A; Pohlman U; Waltz T; Gonzalez R; Haas T; Bieri O; Fischer D J Neurol; 2013 Apr; 260(4):969-74. PubMed ID: 23138982 [TBL] [Abstract][Full Text] [Related]
52. Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients. Janssen B; Voet N; Geurts A; van Engelen B; Heerschap A Neurology; 2016 May; 86(18):1700-7. PubMed ID: 27037227 [TBL] [Abstract][Full Text] [Related]
53. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study. Mavrogeni S; Tzelepis GE; Athanasopoulos G; Maounis T; Douskou M; Papavasiliou A; Cokkinos DV Chest; 2005 Jan; 127(1):143-8. PubMed ID: 15653975 [TBL] [Abstract][Full Text] [Related]
54. Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort. Willcocks RJ; Rooney WD; Triplett WT; Forbes SC; Lott DJ; Senesac CR; Daniels MJ; Wang DJ; Harrington AT; Tennekoon GI; Russman BS; Finanger EL; Byrne BJ; Finkel RS; Walter GA; Sweeney HL; Vandenborne K Ann Neurol; 2016 Apr; 79(4):535-47. PubMed ID: 26891991 [TBL] [Abstract][Full Text] [Related]
55. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials. Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492 [TBL] [Abstract][Full Text] [Related]
56. Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy. Eichinger K; Heatwole C; Heininger S; Stinson N; Matichak Stock C; Grosmann C; Wagner KR; Tawil R; Statland JM; Muscle Nerve; 2017 Mar; 55(3):333-337. PubMed ID: 27421252 [TBL] [Abstract][Full Text] [Related]
57. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale. Suslov V; Suslova G; Lytaev S Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710 [TBL] [Abstract][Full Text] [Related]
58. Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study. Li W; Zheng Y; Zhang W; Wang Z; Xiao J; Yuan Y Neuromuscul Disord; 2015 May; 25(5):375-80. PubMed ID: 25701397 [TBL] [Abstract][Full Text] [Related]
59. Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy. Chrzanowski SM; Baligand C; Willcocks RJ; Deol J; Schmalfuss I; Lott DJ; Daniels MJ; Senesac C; Walter GA; Vandenborne K Acta Myol; 2017 Sep; 36(3):151-162. PubMed ID: 29774305 [TBL] [Abstract][Full Text] [Related]
60. Non-uniform muscle fat replacement along the proximodistal axis in Duchenne muscular dystrophy. Hooijmans MT; Niks EH; Burakiewicz J; Anastasopoulos C; van den Berg SI; van Zwet E; Webb AG; Verschuuren JJGM; Kan HE Neuromuscul Disord; 2017 May; 27(5):458-464. PubMed ID: 28302391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]